From: Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial
Grade
Diarrhea
Gastritis
Proctitis
Hematochezia
Highest during follow-up
Highest at last follow-up
Cohort 1
1
3
2
0
Cohort 2